EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosome-derived miR-548ag drives hepatic lipid accumulation via upregulating FASN through inhibition of DNMT3B

Xiaolong Chu, Yanting Hou, Chaoling Peng, Wei Li, Maodi Liang, Jin Mei, Meiyu Qian, Juan Wang, Shibo Xu, Yidan Jiang, Xin Wen, Yao Chen und 4 weitere

Journal of Lipid Research · 2025

DOI: 10.1016/j.jlr.2025.100818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Xiaolong Chu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Department of Medical Genetics, Medical College of Tarim…. Hauptthemen laut MEDLINE: MicroRNAs, DNA (Cytosine-5-)-Methyltransferases, Fatty Acid Synthase, Type I, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease worldwide. This study investigates the role of serum miR-548ag in regulating lipid metabolism and its contribution to MASLD in obesity. We found that miR-548ag levels were significantly elevated in the serum of both obese and MASLD patients and positively correlated with body mass index, fasting plasma glucose, triglycerides, total cholesterol, LDL, HDL, aspartate aminotransferase, and alanine aminotransferase levels. Additionally, miR-548ag expression was significantly higher in the liver and abdominal adipose tissue of obese individuals than those of normal weight. In vitro studies in HepG2 and L02 cells, along with previous findings, demonstrated that miR-548ag promotes fatty acid synthase (FASN) expression by inhibiting DNA methyltransferase 3B (DNMT3B), thereby enhancing lipid synthesis. This was confirmed in two mouse models: one with tail vein injections of miR-548ag mimic/inhibitor adeno-associated viruses and another with tail vein injections of exosomes from serum of normal-weight and obese individuals. Both models showed that miR-548ag upregulated FASN through DNMT3B inhibition, leading to increased lipid synthesis and larger hepatic lipid droplets, effects that were reversed by miR-548ag inhibition. Together, this study revealed a significant increase in the levels of exosome miR-548ag in the serum of obese patients, which reaches the liver through blood circulation. In the liver, miR-548ag can target and inhibit DNMT3B, upregulate FASN expression, and increase hepatic lipid synthesis, thereby promoting the development of MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDNA (Cytosine-5-)-MethyltransferasesFatty Acid Synthase, Type ILiverUp-RegulationLipid MetabolismExosomesFatty LiverHumansAnimalsMiceDNA Methyltransferase 3BMaleHep G2 CellsObesityFemaleMice, Inbred C57BLMiddle Aged

Stichwörter der Autor:innen

DNMT3BFASNMASLDmiR-548agobesity

Substanzen

MicroRNAsDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BFatty Acid Synthase, Type IFASN protein, human

Autor:innen und Institutionen

  • Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Department of Medical Genetics, Medical College of Tarim University, Alar, Xinjiang, China.
  • Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang, China.
  • First Affiliated Hospital of Shihezi University School of Medicine, Shihezi, Xinjiang, China.
  • Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Department of Medical Genetics, Medical College of Tarim University, Alar, Xinjiang, China. Electronic address: xiejianxin9017…
  • Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang, China. Electronic address: wangcuizh…
  • Department of Basic Medicine, Medical College, Shihezi University, Shihezi, Xinjiang, China; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang, China. Electronic address: zhangjuny…

Förderung

  • National Natural Science Foundation of China
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Zitieren

APA

Chu, X., Hou, Y., Peng, C., Li, W., Liang, M., Mei, J., Qian, M., Wang, J., Xu, S., Jiang, Y., Wen, X., Chen, Y., Yuan, F., Xie, J., Wang, C., & Zhang, J. (2025). Exosome-derived miR-548ag drives hepatic lipid accumulation via upregulating FASN through inhibition of DNMT3B. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100818

Vancouver

Chu X, Hou Y, Peng C, Li W, Liang M, Mei J, et al. Exosome-derived miR-548ag drives hepatic lipid accumulation via upregulating FASN through inhibition of DNMT3B. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100818

BibTeX
@article{Chu2025,
  author = {Chu, Xiaolong and Hou, Yanting and Peng, Chaoling and Li, Wei and Liang, Maodi and Mei, Jin and Qian, Meiyu and Wang, Juan and Xu, Shibo and Jiang, Yidan and Wen, Xin and Chen, Yao and Yuan, Fangyuan and Xie, Jianxin and Wang, Cuizhe and Zhang, Jun},
  title = {Exosome-derived miR-548ag drives hepatic lipid accumulation via upregulating FASN through inhibition of DNMT3B},
  journal = {Journal of Lipid Research},
  year = {2025},
  doi = {10.1016/j.jlr.2025.100818}
}
Kostenlos starten →